End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
89.4 TWD | -2.08% | -8.68% | -21.58% |
Apr. 23 | Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 8.95B 288B |
---|---|---|---|---|---|
Net income 2022 | -314M -10.09B | Net income 2023 | -687M -22.08B | EV / Sales 2022 | - |
Net cash position 2022 | 1.6B 51.39B | Net cash position 2023 | 3.22B 103B | EV / Sales 2023 | - |
P/E ratio 2022 |
-39.8
x | P/E ratio 2023 |
-12.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | -2.08% | ||
1 week | -8.68% | ||
Current month | -5.60% | ||
1 month | +7.58% | ||
3 months | -17.98% | ||
6 months | -19.10% | ||
Current year | -21.58% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
FOU | Founder | 46 | 16-05-11 |
Wan Shan Chen
DFI | Director of Finance/CFO | 38 | 16-05-31 |
Hung Wei Chen
COO | Chief Operating Officer | 43 | 16-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hsien Hua Huang
BRD | Director/Board Member | - | 18-09-26 |
San Chien Tu
BRD | Director/Board Member | - | 18-09-26 |
Chan Yue Li
BRD | Director/Board Member | 52 | 16-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +4.91% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 89.4 | -2.08% | 180,228 |
24-05-13 | 91.3 | -1.72% | 220,152 |
24-05-10 | 92.9 | -3.03% | 189,175 |
24-05-09 | 95.8 | +0.95% | 145,202 |
24-05-08 | 94.9 | -3.06% | 252,003 |
End-of-day quote Taipei Exchange, May 13, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-21.58% | 217M | |
+31.36% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.69% | 239B | |
+10.12% | 210B | |
-7.12% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- 6696 Stock